PAR 29.3% 26.5¢ paradigm biopharmaceuticals limited..

Ann: Paradigm Increases Presence at OARSI World Congress 2023, page-44

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,381 Posts.
    lightbulb Created with Sketch. 6924
    Nicely written Dungiven.

    Further down the track I can see these kind of tests you mention being put into practice at scale. We know the manifestation of OA is generally slow, it takes years for it to progress on its destructive path. The hairline micro fractures in cartilage and surrounding tissues go undetected for years. The statistic that you have a 50% chance of developing OA within ten years of an injury such as an ACL or meniscus tear is telling.

    VK is duly and dually charged with heading up the OA biomarker consortium reporting back to the FDA, its amazing to have her as a consultant to us.

    I also wait patiently to hear more from her and of course watch with eager anticipation for our future data.



    Last edited by Mozzarc: 06/02/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.